Skip to main page content

PubMed Journals

Find, Browse, and Follow Biomedical Journals

New on 2017 Jan 04:

Dietary Advice Interventions in Pregnancy for Preventing Gestational Diabetes Mellitus
J Tieu et al. Cochrane Database Syst Rev 1, CD006674.
Very low-quality evidence from five trials suggests a possible reduction in GDM risk for women receiving dietary advice versus standard care, and low-quality evidence from four trials suggests no clear difference for women receiving low- versus moderate- to high-GI dietary advice. A possible reducti ...
  • Review Article
Gabapentin for Fibromyalgia Pain in Adults
TE Cooper et al. Cochrane Database Syst Rev 1, CD012188.
We have only very low quality evidence and are very uncertain about estimates of benefit and harm because of a small amount of data from a single trial. There is insufficient evidence to support or refute the suggestion that gabapentin reduces pain in fibromyalgia.
  • Review Article
Inhaled Nitric Oxide for Respiratory Failure in Preterm Infants
KJ Barrington et al. Cochrane Database Syst Rev 1, CD000509.
iNO does not appear to be effective as rescue therapy for the very ill preterm infant. Early routine use of iNO in preterm infants with respiratory disease does not prevent serious brain injury or improve survival without BPD. Later use of iNO to prevent BPD could be effective, but current 95% confi ...
  • Review Article
Yoga for Improving Health-Related Quality of Life, Mental Health and Cancer-Related Symptoms in Women Diagnosed With Breast Cancer
H Cramer et al. Cochrane Database Syst Rev 1, CD010802.
Moderate-quality evidence supports the recommendation of yoga as a supportive intervention for improving health-related quality of life and reducing fatigue and sleep disturbances when compared with no therapy, as well as for reducing depression, anxiety and fatigue, when compared with psychosocial/ ...
  • Review Article
Fulvestrant for Hormone-Sensitive Metastatic Breast Cancer
CI Lee et al. Cochrane Database Syst Rev 1, CD011093.
For postmenopausal women with advanced hormone-sensitive breast cancer, fulvestrant is at least as effective and safe as the comparator endocrine therapies in the included studies. However, fulvestrant may be potentially more effective than current therapies when given at 500 mg, though this higher ...
  • Review Article